BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19151650)

  • 1. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
    Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R
    Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
    Tsai J; Chen GS; Lu YW; Wu CS; Lan CC
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular prognosis in Behçet's disease].
    Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
    J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ocular manifestations of Behçet's disease.
    Davatchi F
    Adv Exp Med Biol; 2003; 528():487-91. PubMed ID: 12918750
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 8. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
    Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of ocular involvement in Behçet's disease].
    Belkhadir K; Boutimzine N; Laghmari M; Amazouzi A; Tachfouti S; Cherkaoui O
    J Fr Ophtalmol; 2019 Jun; 42(6):612-617. PubMed ID: 31088739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
    Deuter CM; Zierhut M; Möhle A; Vonthein R; Stöbiger N; Kötter I
    Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.
    Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A
    Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uveitic glaucoma in Behçet's disease: When everything gets complicated].
    Belkhadir K; Boutimzine N; Tachfouti S; Laghmari M; Amazouzi A; Cherkaoui O
    J Fr Ophtalmol; 2020 Sep; 43(7):635-641. PubMed ID: 32622636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Eye and Behçet's disease].
    Binisti P
    Rev Prat; 1999 Nov; 49(18):1999-2003. PubMed ID: 10626485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
    Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
    Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and outcome of uveitis in children.
    Friling R; Kramer M; Snir M; Axer-Siegel R; Weinberger D; Mukamel M
    J AAPOS; 2005 Aug; 9(4):379-82. PubMed ID: 16102490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radial artery occlusion, a rare presentation of Behçet's disease.
    Gera C; Jose W; Malhotra N; Malhotra V; Dhanoa J
    J Assoc Physicians India; 2008 Aug; 56():643-4. PubMed ID: 19051714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical-immunological disorders in uveitis in patients with Behçet's syndrome].
    Teplinskaia LE; Kaliberdina AF; Zaĭtseva NS; Bulanova TD; Katsnel'son LA
    Vestn Oftalmol; 1994; 110(3):23-5. PubMed ID: 7810037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.